Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.33 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL9851406 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL179840 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL11125163 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL3467693 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL936385 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL6730524 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL10977701 | 0.88 | NAPRT (0.60) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL28227676 | 0.86 | NAPRT (0.39) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL5844201 | 0.85 | NAPRT (0.56) | NAPRTTSHRTDP1KMT2AMEN1 | |
| Pyridine SCHEMBL2064519 | 0.85 | NAPRT (0.56) | NAPRTTSHRTDP1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 657 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260097052-A1 | NOVEL ORAL CANNABINOID FORMULATIONS | ESOLATE PHARMACEUTICALS LTD (GB) | 2026-04-09 | — | — | US | claimed |
| WO-2025099099-A1 | NOVEL ORAL CANNABINOID FORMULATIONS | ESOLATE PHARMACEUTICALS LIMITED (GB) | 2025-05-15 | — | — | WO | claimed |
| EP-4333991-A1 | ORAL CARE AGENT | Dr. Kurt Wolff GmbH & Co. KG (DE) | 2024-03-13 | — | — | EP | claimed |
| WO-2022233361-A1 | ORAL CARE AGENT | DR. KURT WOLFF GMBH & CO. KG (DE) | 2022-11-10 | — | — | WO | claimed |
| CN-114509926-A | Developing solution, preparation method thereof and developing method of photoresist | 福建中安高新材料研究院有限公司 | 2022-05-17 | — | — | CN | claimed |
| EP-2554646-B1 | BIODEGRADABLE LUBRICATING OIL COMPOSITION HAVING FLAME RETARDANCY | IDEMITSU KOSAN CO (JP) | 2019-06-12 | — | — | EP | claimed |
| EP-2111135-B1 | ORAL CARE IMPLEMENT HAVING FLUID DELIVERY SYSTEM | COLGATE PALMOLIVE CO (US) | 2018-07-04 | — | — | EP | claimed |
| EP-2117376-B1 | ORAL CARE IMPLEMENT HOUSING AN ORAL CARE AGENT | COLGATE PALMOLIVE CO (US) | 2017-11-15 | — | — | EP | claimed |
| EP-1903905-B1 | ORAL CARE IMPLEMENT HAVING RESERVOIR FOR DISPENSING ACTIVE AGENT | COLGATE PALMOLIVE CO (US) | 2016-12-28 | — | — | EP | claimed |
| US-9480646-B2 | Sustained release siRNA for ocular drug delivery | ALLERGAN, INC. (US) | 2016-11-01 | — | — | US | claimed |
| US-20030091514-A1 | Oral care compositions comprising diglycerol | NOVILLE, INC. | 2003-05-15 | — | — | US | claimed |
| US-20030091600-A1 | PROCESS FOR MAKING PERSONAL CARE COMPOSITIONS COMPRISING TITANIUM DIOXIDE AND PERSONAL CARE COMPOSITIONS MADE BY THE PROCESS | FIRMENICH SA (CH) | 2003-05-15 | — | — | US | claimed |
| EP-1310233-A2 | Process for making compositions comprising titanium dioxide | Noville, Inc. (US) | 2003-05-14 | — | — | EP | claimed |
| EP-0852148-B1 | Products having anti-microbial activity | SION MICROTEC LTD (IL) | 2002-02-06 | — | — | EP | claimed |
| EP-0920857-A2 | Oral composition for the treatment of halitosis | DENTAID, S.A. (ES) | 1999-06-09 | — | — | EP | claimed |
| EP-0852148-A1 | Products having anti-microbial activity | Sion Narrow-Weaving (IL) | 1998-07-08 | — | — | EP | claimed |
| US-5563051-A | Production of hyaluronic acid | FERMENTECH MEDICAL LIMITED (GB) | 1996-10-08 | — | — | US | claimed |
| EP-0239335-A2 | Non-inflammatory hyaluronic acid fraction and process for preparing it | INTERNATIONAL PHARMACEUTICAL PRODUCTS, INC. (US) | 1987-09-30 | — | — | EP | claimed |
| US-4199564-A | Film-forming alcoholic microbicidal teat dip and method of use thereof | Masti-Kure Products Company, Inc. (US) | 1980-04-22 | — | — | US | claimed |
| US-4137303-A | POLYAMINE-POLYPHOSPHONIC ACID STAIN REMOVING COMPOUND | COLGATE PALMOLIVE COMPANY (US) | 1979-01-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097052-A1 | NOVEL ORAL CANNABINOID FORMULATIONS | CNR2, CNR1, OPRD1 | NAPRT 2323/4885TSHR 3942/4885TDP1 3456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.